Virtual Vision Health adds visual acuity testing to Virtual Eye VR platform

News
Article

According to a news release from the company, the VR platform “disrupt[s] traditional diagnostic methods by offering an untethered, all-in-one diagnostic solution that includes a variety of tests such as visual field, progression analysis, color sensitivity, and now visual acuity testing.”

Virtual Vision Health Virtual Eye VR platform Image credit: Virtual Vision Health

Image credit: Virtual Vision Health

Virtual reality (VR) eye care technology company Virtual Vision Health has announced the launch of visual acuity testing on its Virtual Eye VR platform.1 According to a news release from the company, the VR platform “disrupt[s] traditional diagnostic methods by offering an untethered, all-in-one diagnostic solution that includes a variety of tests such as visual field, progression analysis, color sensitivity, and now visual acuity testing.”

"Virtual reality testing is the future of eye care," said Mark Latina, MD, of Advanced Glaucoma Specialists of Reading, Massachusetts, in the release. "We're moving away from bulky, stationary devices toward more efficient VR-based diagnostics. The Virtual Eye is wireless, portable, and allows testing anywhere in the office, making it a game-changer in patient care."

Allowing for delivery of real time data, the VR platform features a streamlined testing process for eye care providers to conduct multiple exams on a single platform. The device is also wireless and portable, with analytics available through Virtual Vision health’s WebbApp. The device also shortens testing times, which increases patient throughput while maintaining diagnostic accuracy, according to the company.1

"Our growth to over 1100 devices installed globally marks a significant milestone in our mission to modernize vision diagnostics and screen with VR," said Matteo Ziff, CEO of Virtual Vision Health, in the release. "With expanding product offerings and global reach, we remain committed to innovation and accessibility, driving the future of ophthalmic diagnostics and delivering scalable, high-impact solutions for eye care. Visual Acuity is just the beginning for this year."

Reference:
  1. Virtual Vision Health unveils visual acuity testing for VR device. News release. PR Newswire. February 11, 2025. Accessed February 11, 2025. https://www.prnewswire.com/news-releases/virtual-vision-health-unveils-visual-acuity-testing-for-vr-device-302373025.html

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
© 2025 MJH Life Sciences

All rights reserved.